Cannabis

Patients with dermatologic conditions are open to trying medical cannabis products as potential treatments, according to a new study from George Washington University School of Medicine and Health Sciences and University of Maryland researchers.

Nanotechnology delivery systems may be an innovative and effective approach to delivering cannabinoids for skin care, according to a team from the Department of Dermatology at the George Washington University School of Medicine and Health Sciences.

Researchers at SMHS found dermatologists are interested in learning more about and recommending therapeutic cannabinoids to patients.

Hai Chen, M.D. Ph.D., assistant professor of neurology, spoke with Voice of America about the use of CBD oil as a treatment for epilepsy.

Nathaniel DeNicola, M.D., assistant professor of obstetrics and gynecology, discussed research in a Reuters article about the use of marijuana by pregnant teenagers.

Elizabeth Robinson, M.D., a resident in the Department of Dermatology at the GW School of Medicine and Health Sciences, placed third for the Everett C. Fox Memorial Award presented by the American Academy of Dermatology (AAD).

Mikhail Kogan, M.D., assistant professor of medicine, was quoted in an article in the National Post (Canada) about the healthy consumption of medical marijuana.

Mikhail Kogan, M.D., assistant professor of medicine, was quoted in a Washington Post article about the use of medical marijuana containing a high level of cannabidiol.

David A. Belyea, M.D., M.B.A., vice chair and professor in the Department Ophthalmology and director of glaucoma services, was published in JAMA Ophthalmology for his survey of D.C. glaucoma patients who asked for a marijuana prescription after legalization. 

Cathleen Clancy, M.D., associate professor of emergency medicine, was quoted in an article about the harms of synthetic marijuana products because very little is known about them and experts don't know how they will affect the human body.